Delivery Order SPE2DB20D2001-SPE2DB23FM49U
Award Date
4/18/23
Potential Completion Date
4/19/23
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Azelastine 0.1% (137 mcg) Spray, 30 mL, with a firm fixed price of $1,547.25 and an ultimate completion date of September 13, 2024. The contract is not set aside for any small business designation. Amerisourcebergen, through its Corporate Office division, has been awarded this delivery order under a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,037.00 firm fixed-price delivery order is for the supply of Azelastine 0.1% (137 MCG) Spray, 30ML. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a broad range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,428.72 firm fixed-price delivery order is for the supply of Azelastine 0.1% (137 mcg) Spray, 30 ml, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued up to $999,999,999 through December 2025, for delivering a comprehensive range...
This federal contract award, valued at $1,245.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Azelastine 0.1% (137 MCG) spray medication. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to supply a...
This federal contract award is for the delivery of Azelastine 0.1% (137 MCG) Nasal Spray, 30ML to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract is a firm fixed-price delivery order with a ceiling value of $3,585.39 and an ultimate completion date of December 22, 2023. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,234.05 firm fixed-price delivery order is for the supply of Azelastine 0.1% (137 MCG) Spray, a pharmaceutical product. The contract has an ultimate completion date of December 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,392.00 firm fixed price contract is for the supply of 4565433298 - Azelastine 0.1% (137 MCG) Spray, 30ML. It is not a set-aside contract. The delivery order is part of a larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,132.62, is for the delivery of Azelastine 0.1% (137 MCG) Spray, a pharmaceutical product. This order was issued under an Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen's parent company, Cencora, Inc., with a ceiling...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of azelastine 0.1% (137 mcg) nasal spray, a pharmaceutical product. The contract has a ceiling value of $1,144.56 and an ultimate completion date of January 6, 2022. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This federal contract award, with ID SPE2DB20D7059|SPE2DB25FPTQ2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,322.40 firm fixed price delivery order is for the supply of 4566316369 - Azelastine 0.1% (137 MCG) Spray, 30 ML. The contract has an ultimate completion date of November 5, 2024 and was awarded on November 4, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999...